Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Jan;53(1):44–51. doi: 10.1172/JCI107557

The Rapid Changes of Hepatic Glycolytic Enzymes and Fructose-1, 6-Diphosphatase Activities after Intravenous Glucagon in Humans

H L Greene 1, O D Taunton 1, F B Stifel 1, R H Herman 1
PMCID: PMC301436  PMID: 4357616

Abstract

Glucagon (0.04-0.09 mg/kg/min) was given intravenously for either 2 or 3 min to eight patients with fasting-induced hypoglycemia. One child had hepatic phosphorylase deficiency, two children had glucose-6-phosphatase deficiency, two children had debrancher enzyme (amylo-1,6-glucosidase) deficiency, and two children and one adult had decreased hepatic fructose-1,6-diphosphatase (FDPase) activity. Liver biopsy specimens were obtained before and immediately after the glucagon infusion. The glucagon caused a significant increase in the activity of FDPase (from 50±10.0 to 72±11.7 nmol/mg protein/min) and a significant decrease in the activities of phosphofructokinase (PFK) (from 92±6.1 to 41±8.1 nmol/mg protein/min) and pyruvate kinase (PK) (from 309±39.4 to 165±23.9 nmol/mg protein/min). The glucagon infusion also caused a significant increase in hepatic cyclic AMP concentrations (from 41±2.6 to 233±35.6 pmol/mg protein). Two patients with debrancher enzyme deficiency who had biopsy specimens taken 5 min after the glucagon infusion had persistence of enzyme and cyclic AMP changes for at least 5 min. One child with glucose-6-phosphatase deficiency was given intravenous glucose (150 mg/kg/min) for a period of 5 min after the glucagon infusion and biopsy. The plasma insulin concentration increased from 8 to 152 μU/ml and blood glucose increased from 72 to 204 mg/100 ml. A third liver biopsy specimen was obtained immediately after the glucose infusion and showed that the glucagon-induced effects on PFK and FDPase were completely reversed. The glucagon infusion caused an increase in hepatic cyclic AMP concentration from 38 to 431 pmol/mg protein but the glucose infusion caused only a slight decrease in hepatic cyclic AMP concentration (from 431 to 384 pmol/mg protein), which did not appear to be sufficient to account for the changes in enzyme activities. Hepatic glucose-6-phosphatase and fructose-1,6-diphosphate aldolase activities were not altered by either the glucagon or the glucose infusion in any patients. Cyclic AMP (0.05 mmol/kg) was injected into the portal vein of adult rats and caused enzyme changes similar to those seen with glucagon administration in humans. Our findings suggest that rapid changes in the activities of PFK, PK, and FDPase are important in the regulation of hepatic glycolysis and gluconeogenesis, respectively, in humans and that cyclic AMP may mediate the glucagon- but probably not the glucose-insulin-induced changes in enzyme activities.

Full text

PDF
44

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERTHET J., RALL T. W., SUTHERLAND E. W. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem. 1957 Jan;224(1):463–475. [PubMed] [Google Scholar]
  2. Baker L., Winegrad A. I. Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet. 1970 Jul 4;2(7662):13–16. doi: 10.1016/s0140-6736(70)92474-8. [DOI] [PubMed] [Google Scholar]
  3. Bishop J. S., Larner J. Rapid activation-inactivation of liver uridine diphosphate glucose-glycogen transferase and phosphorylase by insulin and glucagon in vivo. J Biol Chem. 1967 Mar 25;242(6):1354–1356. [PubMed] [Google Scholar]
  4. Blair J. B., Cook D. E., Lardy H. A. Influence of glucagon on the metabolism of xylitol and dihydroxyacetone in the isolated perfused rat liver. J Biol Chem. 1973 May 25;248(10):3601–3607. [PubMed] [Google Scholar]
  5. Exton J. H. Gluconeogenesis. Metabolism. 1972 Oct;21(10):945–990. doi: 10.1016/0026-0495(72)90028-5. [DOI] [PubMed] [Google Scholar]
  6. Exton J. H., Mallette L. E., Jefferson L. S., Wong E. H., Friedmann N., Miller T. B., Jr, Park C. R. The hormonal control of hepatic gluconeogenesis. Recent Prog Horm Res. 1970;26:411–461. doi: 10.1016/b978-0-12-571126-5.50014-5. [DOI] [PubMed] [Google Scholar]
  7. Exton J. H., Park C. R. Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats. J Biol Chem. 1967 Jun 10;242(11):2622–2636. [PubMed] [Google Scholar]
  8. Exton J. H., Park C. R. The role of cyclic AMP in the control of liver metabolism. Adv Enzyme Regul. 1968;6:391–407. doi: 10.1016/0065-2571(68)90024-1. [DOI] [PubMed] [Google Scholar]
  9. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greene H. L., Stifel F. B., Herman R. H. "Ketotic hypoglycemia" due to hepatic fructose-1,6-diphosphatase deficiency: treatment with folic acid. Am J Dis Child. 1972 Sep;124(3):415–418. doi: 10.1001/archpedi.1972.02110150113019. [DOI] [PubMed] [Google Scholar]
  11. Jost J. P., Hsie A., Hughes S. D., Ryan L. Role of cyclic adenosine 3',5'-monophosphate in the induction of hepatic enzymes. I. Kinetics of the induction of rat liver serine dehydratase by cyclic adenosine 3',5'-monophosphate. J Biol Chem. 1970 Jan 25;245(2):351–357. [PubMed] [Google Scholar]
  12. LEA M. A., WALKER D. G. FACTORS AFFECTING HEPATIC GLYCOLYSIS AND SOME CHANGES THAT OCCUR DURING DEVELOPMENT. Biochem J. 1965 Mar;94:655–665. doi: 10.1042/bj0940655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Mansour T. E. Kinetic and physical properties of phosphofructokinase. Adv Enzyme Regul. 1970;8:37–52. doi: 10.1016/0065-2571(70)90007-5. [DOI] [PubMed] [Google Scholar]
  15. Menahan L. A., Wieland O. The role of endogenous lipid in gluconeogenesis and ketogenesis of perfused rat liver. Eur J Biochem. 1969 Jun;9(2):182–188. doi: 10.1111/j.1432-1033.1969.tb00593.x. [DOI] [PubMed] [Google Scholar]
  16. Mendicino J., Beaudreau C., Bhattacharyya R. N. Reversible inactivation of D-fructose 1,6-diphosphatase by adenosine triphosphate and cyclic 3' ,5'-adenosine monophosphate. Arch Biochem Biophys. 1966 Sep 26;116(1):436–445. doi: 10.1016/0003-9861(66)90050-6. [DOI] [PubMed] [Google Scholar]
  17. Mäenpä P. H., Raivio K. O., Kekomäki M. P. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science. 1968 Sep 20;161(3847):1253–1254. doi: 10.1126/science.161.3847.1253. [DOI] [PubMed] [Google Scholar]
  18. Pontremoli S., Luppis B., Traniello S., Wood W. A., Horecker B. L. Fructose diphosphatase from rabbit liver. 3. Nature of the groups reactive with dinitrofluorobenzene. J Biol Chem. 1965 Sep;240(9):3469–3472. [PubMed] [Google Scholar]
  19. Raivio K. O., Kekomäki M. P., Mäenpä P. H. Depletion of liver adenine nucleotides induced by D-fructose. Dose-dependence and specificity of the fructose effect. Biochem Pharmacol. 1969 Oct;18(10):2615–2624. doi: 10.1016/0006-2952(69)90192-0. [DOI] [PubMed] [Google Scholar]
  20. Rosensweig N. S., Herman R. H., Stifel F. B., Herman Y. F. Regulation of human jejunal glycolytic enzymes by oral folic acid. J Clin Invest. 1969 Nov;48(11):2038–2045. doi: 10.1172/JCI106169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ross B. D., Hems R., Krebs H. A. The rate of gluconeogenesis from various precursors in the perfused rat liver. Biochem J. 1967 Mar;102(3):942–951. doi: 10.1042/bj1020942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SPOLTER P. D., ADELMAN R. C., WEINHOUSE S. DISTINCTIVE PROPERTIES OF NATIVE AND CARBOXYPEPTIDASE-TREATED ALDOLASES OF RABBIT MUSCLE AND LIVER. J Biol Chem. 1965 Mar;240:1327–1337. [PubMed] [Google Scholar]
  23. Stifel F. B., Rosenweig N. S., Zakim D., Herman R. H. Dietary regulation of glycolytic enzymes. I. Adaptive changes in rat jejunum. Biochim Biophys Acta. 1968 Dec 23;170(2):221–227. doi: 10.1016/0304-4165(68)90001-9. [DOI] [PubMed] [Google Scholar]
  24. Taunton O. D., Stifel F. B., Greene H. L., Herman R. H. Rapid reciprocal changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase following glucagon and insulin injection in vivo. Biochem Biophys Res Commun. 1972 Sep 26;48(6):1663–1670. doi: 10.1016/0006-291x(72)90906-0. [DOI] [PubMed] [Google Scholar]
  25. Teufel H., Menahan L. A., Shipp J. C., Böning S., Wieland O. Effect of oleic acid on the oxidation and gluconeogenesis from [1-14C]pyruvate in the perfused rat liver. Eur J Biochem. 1967 Sep;2(2):182–186. doi: 10.1111/j.1432-1033.1967.tb00124.x. [DOI] [PubMed] [Google Scholar]
  26. VINUELA E., SALAS M., SOLS A. Glucokinase and hexokinase in liver in relation to glycogen synthesis. J Biol Chem. 1963 Mar;238:1175–1177. [PubMed] [Google Scholar]
  27. Veneziale C. M. Gluconeogenesis from fructose in isolated rat liver. Stimulation by glucagon. Biochemistry. 1971 Aug 31;10(18):3443–3447. doi: 10.1021/bi00794a020. [DOI] [PubMed] [Google Scholar]
  28. WEBER G., SINGHAL R. L., SRIVASTAVA S. K. INSULIN: SUPPRESSOR OF BIOSYNTHESIS OF HEPATIC GLUCONEOGENIC ENZYMES. Proc Natl Acad Sci U S A. 1965 Jan;53:96–104. doi: 10.1073/pnas.53.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weber G., Lea M. A., Fisher E. A., Stamm N. B. Regulatory pattern of liver carbohydrate metabolizing enzymes: insulin as inducer of key glycolytic enzymes. Enzymol Biol Clin (Basel) 1966;7(1):11–24. doi: 10.1159/000457201. [DOI] [PubMed] [Google Scholar]
  30. Weber G., Lea M. A., Stamm N. B. Sequential feedback inhibition and regulation of liver carbohydrate metabolism through control of enzyme activity. Adv Enzyme Regul. 1968;6:101–123. doi: 10.1016/0065-2571(68)90009-5. [DOI] [PubMed] [Google Scholar]
  31. Wicks W. D. Induction of hepatic enzymes by adenosine 3',5'-monophosphate in organ culture. J Biol Chem. 1969 Jul 25;244(14):3941–3950. [PubMed] [Google Scholar]
  32. Williamson J. R., Browning E. T., Thurman R. G., Scholz R. Inhibition of glucagon effects in perfused rat liver by (+)decanoylcarnitine. J Biol Chem. 1969 Sep 25;244(18):5055–5064. [PubMed] [Google Scholar]
  33. Woods H. F., Eggleston L. V., Krebs H. A. The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem J. 1970 Sep;119(3):501–510. doi: 10.1042/bj1190501. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES